Luoxin Pharmaceuticals Group Stock Co Ltd (002793) — Net Asset Momentum
Luoxin Pharmaceuticals Group Stock Co Ltd (002793) recorded a net asset momentum of -15.3% as of December 2025, with net assets of CN¥1.24 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Luoxin Pharmaceuticals Group Stock Co Lt book value and equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Luoxin Pharmaceuticals Group Stock Co Ltd Net Asset Momentum (2011–2025)
This chart tracks Luoxin Pharmaceuticals Group Stock Co Ltd's year-over-year net asset growth across 15 annual reporting periods from 2011 to 2025. The most recent momentum reading is -15.3%, with net assets of CN¥1.24 Billion CNY as of December 2025. For live market cap and overall valuation, see Luoxin Pharmaceuticals Group Stock Co Lt stock valuation.
Annual Net Asset History for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2025)
The table below shows the complete annual net asset history for Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2025, covering 15 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check 002793 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.24 Billion | CN¥3.73 Billion | CN¥2.49 Billion | ▼ -15.3% |
| 2024 | CN¥1.46 Billion | CN¥4.34 Billion | CN¥2.88 Billion | ▼ -43.3% |
| 2023 | CN¥2.57 Billion | CN¥5.12 Billion | CN¥2.54 Billion | ▼ -22.2% |
| 2022 | CN¥3.31 Billion | CN¥8.11 Billion | CN¥4.80 Billion | ▼ -30.2% |
| 2021 | CN¥4.74 Billion | CN¥9.50 Billion | CN¥4.76 Billion | ▲ +8.9% |
| 2020 | CN¥4.35 Billion | CN¥7.72 Billion | CN¥3.37 Billion | ▲ +9.8% |
| 2019 | CN¥3.96 Billion | CN¥7.46 Billion | CN¥3.50 Billion | ▲ +335.4% |
| 2018 | CN¥909.89 Million | CN¥1.40 Billion | CN¥491.85 Million | ▲ +20.6% |
| 2017 | CN¥754.19 Million | CN¥898.93 Million | CN¥144.74 Million | ▲ +8.0% |
| 2016 | CN¥698.33 Million | CN¥812.89 Million | CN¥114.56 Million | ▲ +105.7% |
| 2015 | CN¥339.50 Million | CN¥549.60 Million | CN¥210.10 Million | ▲ +7.6% |
| 2014 | CN¥315.46 Million | CN¥447.86 Million | CN¥132.40 Million | ▲ +25.4% |
| 2013 | CN¥251.50 Million | CN¥363.30 Million | CN¥111.80 Million | ▲ +22.4% |
| 2012 | CN¥205.54 Million | CN¥372.31 Million | CN¥166.77 Million | ▲ +35.3% |
| 2011 | CN¥151.87 Million | CN¥271.94 Million | CN¥120.07 Million | — |